AI-generated summary
The authors compared morphine use in 280 head and neck cancer patients receiving radiotherapy, with preventive photobiomodulation given to one group and a matched historical control group. Patients receiving photobiomodulation used less morphine at the end of radiotherapy and one month later, but rates of severe oral mucositis were the same in both groups. The study was a matched historical cohort, so it cannot establish cause and effect.
- Participants
- 280
- Who or what was studied
- Adults with oropharyngeal or oral cavity cancer who were opioid-naive and receiving curative-intent radiotherapy, including a matched historical control cohort
- Wavelengths
- 660, 810 nm
- Limits stated in the abstract
- The control group was a historical cohort treated in an earlier period, so the comparison is observational and may be affected by differences over time.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm, 810 nm
- Energy density (fluence)
- 2.25 J/cm2, 6 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, GRADE, Light-emitting diode, Oral mucositis. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.